Consensus ESG Ratings
Member Sign In
ESG News For Innovation Pharmaceuticals Inc.
These sites contributed news to this page:
-
CytoAgents Receives Funding to Accelerate COVID-19 Clinical Trials for Cytokine Storm Treatment From Richard King Mellon Foundation
$250,000 Investment Part of Rapid Response Pandemic Solutions Package